Natalie Chilaka, MD
Orthopaedic Surgery · Glen Burnie, MDNPI 1346412418
Payments from drug & device makers
Across 38 payments — averaging $94.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Synthes GmbH$3K
- Johnson & Johnson$131
- Stryker$96
- Bone Support Inc.$90
- Kerecis Limited$57
- Amgen$43
- plus $492 from 25 others
What the payments were for
- Speaking & faculty fees$1,50042%
- Travel & lodging$1,05129%
- Food & beverage$1,04229%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Synthes GmbH | 4 | $2,684 |
| Johnson & Johnson | 1 | $131 |
| Stryker | 2 | $96 |
| Bone Support Inc. | 1 | $90 |
| Kerecis Limited | 1 | $57 |
| Amgen | 2 | $43 |
| Neurelis, Inc. | 2 | $35 |
| Pfizer | 2 | $34 |
| UCB, Inc. | 1 | $27 |
| Averitas Pharma Inc. | 1 | $25 |
| Vertos Medical, Inc. | 1 | $24 |
| Supreme Orthopedic Systems, LLC | 1 | $23 |
| Radius Health, Inc. | 1 | $23 |
| Biogen | 1 | $22 |
| KCI USA, Inc. | 1 | $20 |
| SK Life Science, Inc. | 1 | $20 |
| AstraZeneca | 1 | $20 |
| Smith+Nephew | 1 | $20 |
| Intrinsic Therapeutics | 1 | $19 |
| Ultragenyx Pharmaceutical Inc. | 1 | $19 |
| Lundbeck LLC | 1 | $18 |
| Solventum Corporation | 1 | $16 |
| AbbVie | 1 | $16 |
| Sanara Medtech Inc. | 1 | $15 |
| Orthofix Medical, Inc. | 1 | $15 |
| Acumed LLC | 1 | $15 |
| CSL Behring | 1 | $14 |
| Acadia Pharmaceuticals Inc | 1 | $14 |
| Avion Pharmaceuticals | 1 | $14 |
| Lilly USA, LLC | 1 | $14 |
| Arbor Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NA$131
How this compares
$3,593 in reported general payments places this provider in the 50th percentile of 378 orthopaedic surgery providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Alendronate Sodium | 22 | $328 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Glen Burnie
- Amir MoinfarGlen Burnie$142K
- Mark MyersonBaltimore$10.5M
- David DaluryTowson$8.1M
- Anand MurthiBaltimore$5.4M
- Timothy CoddTowson$3.7M
- Khaled KebaishBaltimore$3.5M
- Hamid HassanzadehBethesda$2M
- Michael AinLutherville$1.6M
- Paul SponsellerBaltimore$1.5M
- Shawn StandardBaltimore$1.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.